指南与共识消化、代谢与肾脏急症

急性和慢性胰腺炎生活质量评估工具:基于COSMIN的共识标准方法

Quality of life instruments in acute and chronic pancreatitis: a consensus-based standards for the selection of health measurement instruments (COSMIN) approach.
指南 / 共识 · HPB (Oxford) · 2024-04-26
一句话结论系统评价显示胰腺炎生活质量评估工具异质性大,仅胃肠道生活质量指数和PAN-PROMISE符合COSMIN推荐标准。

该研究通过系统评价MEDLINE、EMBASE和Web of Science截至2023年6月28日的文献(PROSPERO: CRD42021274743),纳入138项前瞻性研究,识别出41种用于急慢性胰腺炎患者健康相关生活质量评估的工具,并采用COSMIN指南和GRADE方法评估其方法学质量。结果显示69.8%(n=26)的工具为通用健康相关生活质量量表,仅10种(24.3%)内容效度充分(涵盖≥5个WHO生活质量领域条目),仅9种(21.9%)有公众和患者参与。仅胃肠道生活质量指数和PAN-PROMISE符合COSMIN方法学评估推荐使用标准。结论认为现有工具异质性显著,几乎所有工具均被认为不充分,需要稳健、经过验证且相关的工具来更好地理解和确定改善胰腺炎患者生活质量的干预措施。

要点

  • 138项前瞻性研究共识别41种生活质量评估工具,其中69.8%(n=26)为通用量表,仅24.3%(n=10)内容效度充分(涵盖≥5个WHO生活质量领域)。
  • 仅21.9%(n=9)的工具纳入了公众和患者参与。
  • 基于COSMIN方法学评估,仅胃肠道生活质量指数和PAN-PROMISE符合推荐使用标准。
  • 几乎所有用于胰腺炎生活质量评估的工具均被认为不充分,工具间异质性显著。

适用人群与场景

  • 急性或慢性胰腺炎患者(前瞻性研究纳入人群)。

诊断标准与关键阈值

  • 采用COSMIN指南评估工具方法学质量,内容效度充分定义为涵盖≥5个WHO生活质量领域的条目。
  • 推荐使用标准基于COSMIN标准,并依据WHO生活质量领域评估。

研究设计与关键结果

  • 系统评价MEDLINE、EMBASE和Web of Science截至2023年6月28日(PROSPERO: CRD42021274743),从3850条记录中筛选,纳入138项研究,识别41种生活质量评估工具。
  • 工具类型:通用健康相关生活质量26种(69.8%),腹部特异性5种,胰腺特异性10种。
  • 仅10种工具(24.3%)内容效度充分,涵盖≥5个WHO生活质量领域条目。
  • 仅9种工具(21.9%)纳入了公众和患者参与。
  • 仅胃肠道生活质量指数和PAN-PROMISE符合COSMIN方法学评估推荐使用标准。

证据类型、等级与局限

  • 研究类型:系统评价(PROSPERO: CRD42021274743),采用COSMIN指南和GRADE方法评估方法学质量。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 基于COSMIN方法学评估,仅胃肠道生活质量指数和PAN-PROMISE符合推荐使用标准。
  • 几乎所有用于胰腺炎生活质量评估的工具均被认为不充分,工具间异质性显著。
  • 作者认为需要稳健、经过验证且相关的工具来更好地理解和确定改善胰腺炎患者生活质量的干预措施。

指南或共识出处

  • COSMIN(COnsensus-based Standards for the selection of health status Measurement Instruments)指南
  • GRADE方法
  • 世界卫生组织(WHO)生活质量领域

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Pancreatitis is a common surgical emergency, associated with pain and poor quality of life for patients. However, assessment of patient-reported outcome measures in these patients is unclear. This study aimed to identify and evaluate the methodological quality of the health-related quality of life instruments used for patients with acute or chronic pancreatitis.

METHODS: Prospective studies that evaluated health-related quality of life in acute or chronic pancreatitis were identified from systematic review of MEDLINE, EMBASE, and Web of Science until 28th June 2023 (PROSPERO: CRD42021274743). Instrument characteristics were extracted, and methodological quality assessed using COSMIN (COnsensus-based Standards for the selection of health status Measurement Instruments) guidelines and GRADE approach. Narrative synthesis was conducted, with recommendations for use based on COSMIN criteria, evaluated according to World Health Organisation (WHO) quality of life domains.

RESULTS: From 3850 records screened, 41 quality of life instruments were identified across 138 studies included. The majority (69.8%, n = 26) were designed to assess general health-related quality of life, whereas the remainder were abdominal-specific (n = 5) or pancreas-specific (n = 10). Only ten instruments (24.3%) demonstrated sufficient content validity, incorporating items in ≥5 WHO quality of life domains. However, only nine instruments (21.9%) incorporated public and patient involvement. Only the Gastrointestinal Quality of Life Index and PAN-PROMISE met the criteria to be recommended for use based on COSMIN methodological assessment.

CONCLUSION: There is significant heterogeneity in instruments used to assess quality of life after pancreatitis, with almost all instruments considered insufficient. Robust, validated, and relevant instruments are needed to better understand and determine appropriate interventions to improve quality of life for these patients.

来源:HPB (Oxford),查看原文。版权归原作者所有。

参考来源

  1. Quality of life instruments in acute and chronic pancreatitis: a consensus-based standards for the selection of health measurement instruments (COSMIN) approach. HPB (Oxford). 2024. PMID: 38735815. doi:10.1016/j.hpb.2024.04.004

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。